# Bio-Active Resveratrol (Polygonum cuspidatum)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/bio-active-resveratrol
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Polygonum cuspidatum, Japanese knotweed, Hu Zhang, Asian knotweed, Mexican bamboo, Fallopia japonica, Reynoutria japonica, Crimson beauty

## Overview

Bio-Active Resveratrol from Polygonum cuspidatum is a stilbenoid polyphenol that activates SIRT1 deacetylase and inhibits NF-κB signaling, producing [antioxidant](/ingredients/condition/antioxidant) and [anti-inflammatory](/ingredients/condition/inflammation) effects. The standardized root extract delivers trans-resveratrol, the biologically active isomer studied for [cardiovascular](/ingredients/condition/heart-health) and metabolic support.

## Health Benefits

• Traditional use for [cardiovascular](/ingredients/condition/heart-health) support (based on historical Chinese medicine applications, no clinical evidence provided) • [Antioxidant activity](/ingredients/condition/antioxidant) demonstrated in vitro through DPPH, ABTS, and FRAP assays (preliminary evidence only) • Traditional use for regulating lipoprotein [metabolism](/ingredients/condition/weight-management) (historical use claim, no clinical validation) • Traditional use for inhibiting platelet aggregation (historical use claim, no clinical validation) • Traditional use for preventing arteriosclerosis (historical use claim, no clinical validation)

## Mechanism of Action

Trans-resveratrol activates SIRT1, a NAD+-dependent deacetylase that regulates PGC-1α and downstream [mitochondrial biogenesis](/ingredients/condition/energy) pathways. It inhibits NF-κB transcription factor activity, reducing [pro-inflammatory cytokine](/ingredients/condition/inflammation) expression including TNF-α and IL-6. Additionally, resveratrol scavenges [reactive oxygen species](/ingredients/condition/antioxidant) by donating hydrogen atoms to DPPH and ABTS radicals, and chelates transition metal ions to suppress Fenton reaction-driven oxidative stress.

## Clinical Summary

Human clinical evidence for Polygonum cuspidatum-derived resveratrol specifically remains limited, with most mechanistic data derived from in vitro DPPH, ABTS, and FRAP assays rather than randomized controlled trials. Studies on isolated trans-resveratrol in humans have used doses ranging from 75 mg to 1000 mg daily, with modest improvements in LDL oxidation and flow-mediated dilation reported in small trials of 19–75 participants. A 2020 meta-analysis of resveratrol RCTs noted statistically significant reductions in triglycerides and [LDL cholesterol](/ingredients/condition/heart-health), though effect sizes were modest and heterogeneity across studies was high. Overall evidence is considered preliminary, and regulatory bodies have not approved resveratrol for any specific health claim.

## Nutritional Profile

Resveratrol (3,5,4'-trihydroxystilbene) is the primary bioactive compound, typically standardized to 98-99% trans-resveratrol from Polygonum cuspidatum (Japanese knotweed) root extract. Raw P. cuspidatum root contains approximately 0.1-1.0% resveratrol by dry weight, with commercial extracts concentrated to deliver standardized doses typically ranging from 50-500mg per serving. Also contains emodin (an anthraquinone glycoside, approximately 0.5-2% in crude extract), piceid (resveratrol-3-O-glucoside, a resveratrol precursor glycoside), and trace amounts of stilbene oligomers including pterostilbene. Macronutrient contribution is negligible as used in supplemental doses. No meaningful vitamin, mineral, fiber, or protein content at supplemental dosing levels. Bioavailability is notably poor for free trans-resveratrol: oral bioavailability estimated at less than 1% due to extensive first-pass hepatic [metabolism](/ingredients/condition/weight-management) and rapid glucuronidation/sulfation; peak plasma concentrations reached within 30-60 minutes post-ingestion but rapidly decline. Piceid form has comparatively slower but potentially more sustained absorption via intestinal hydrolysis. Lipid-based delivery systems or piperine co-administration reported to improve absorption by 1.5-2.3 fold in preliminary studies. Fat co-ingestion modestly enhances absorption.

## Dosage & Preparation

No clinically studied dosage ranges are available as no human trials have been conducted. Extraction studies yield 33.12 mg/g (UV-Vis) or 2.95 mg/g (HPLC) resveratrol from optimized methods, but these are analytical yields, not dosing recommendations. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Resveratrol is generally well-tolerated at doses up to 1000 mg/day in short-term studies, with gastrointestinal discomfort, nausea, and diarrhea reported at higher doses above 2.5 g/day. It inhibits CYP3A4 and CYP2C9 enzymes, creating potential interactions with anticoagulants like warfarin, statins, and immunosuppressants including cyclosporine. Resveratrol exhibits estrogenic activity by binding ERα and ERβ receptors, making it contraindicated in individuals with hormone-sensitive conditions such as estrogen receptor-positive breast cancer. Safety data during pregnancy and lactation is insufficient, and use should be avoided in these populations.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses for resveratrol from Polygonum cuspidatum were found in the research dossier. Available evidence is limited to extraction optimization studies and in vitro antioxidant assays demonstrating [free radical scaveng](/ingredients/condition/antioxidant)ing activity.

## Historical & Cultural Context

Polygonum cuspidatum is a traditional medicinal plant in Chinese medicine, historically used for [cardiovascular health](/ingredients/condition/heart-health) including regulating lipoprotein [metabolism](/ingredients/condition/weight-management), inhibiting platelet aggregation, and preventing arteriosclerosis. The research does not specify the duration of traditional use beyond noting its status as a widely cultivated medicinal plant.

## Synergistic Combinations

Quercetin, Pterostilbene, Curcumin, Green Tea Extract, CoQ10

## Frequently Asked Questions

### What is the difference between Polygonum cuspidatum resveratrol and grape-derived resveratrol?

Polygonum cuspidatum root is the most concentrated natural source of trans-resveratrol, typically standardized to 50–98% trans-resveratrol by weight, far exceeding the trace amounts found in grape skin or red wine. Grape-derived resveratrol supplements often require larger raw material volumes to achieve equivalent dosing, whereas Japanese knotweed (P. cuspidatum) extracts deliver more consistent and quantifiable trans-resveratrol concentrations per capsule.

### How much resveratrol should I take per day?

Clinical studies have used doses ranging from 75 mg to 1000 mg of trans-resveratrol daily, with most cardiovascular-focused trials clustering around 150–500 mg per day. There is no established universally recommended dose, and higher doses above 1000 mg/day have been associated with gastrointestinal side effects without proportionally greater benefit due to resveratrol's poor oral bioavailability (approximately 1% in standard forms).

### Does resveratrol actually extend lifespan in humans?

Lifespan extension by resveratrol has been demonstrated in yeast, C. elegans, and certain fish models through SIRT1 and AMPK pathway activation, but no human longevity data exists. A landmark 2006 Nature study showed resveratrol extended lifespan in obese mice, but translating these results to humans is not scientifically supported at this time. Current human research focuses on metabolic and cardiovascular biomarkers rather than longevity endpoints.

### Can resveratrol interact with blood thinners like warfarin?

Yes, resveratrol inhibits CYP2C9, the primary enzyme responsible for warfarin metabolism, which can elevate plasma warfarin concentrations and increase bleeding risk. Additionally, resveratrol itself has mild antiplatelet activity by inhibiting thromboxane B2 synthesis. Anyone taking anticoagulant or antiplatelet medications should consult a physician before using resveratrol supplements and may require INR monitoring.

### Is bio-active resveratrol from Polygonum cuspidatum safe for women with hormone-sensitive conditions?

Resveratrol acts as a phytoestrogen, binding estrogen receptors ERα and ERβ with weak agonist activity, which raises concern for individuals with estrogen receptor-positive breast cancer, uterine fibroids, or endometriosis. In vitro studies show resveratrol can stimulate proliferation of estrogen-sensitive cancer cell lines at low concentrations, though results are context-dependent. Women with hormone-sensitive conditions should avoid resveratrol supplementation without explicit oncologist or physician guidance.

### What is the bioavailability of resveratrol from Polygonum cuspidatum compared to synthetic resveratrol?

Polygonum cuspidatum resveratrol is derived from a whole-plant source that may contain other polyphenols and compounds that could theoretically support absorption, though direct bioavailability comparisons between plant-derived and synthetic forms remain limited in human studies. Most oral resveratrol, regardless of source, faces significant first-pass metabolism and poor systemic absorption, with studies suggesting less than 5% bioavailability in humans. The presence of additional compounds from the plant extract may enhance absorption through synergistic effects, but this claim requires robust clinical validation. For improved bioavailability, some formulations combine resveratrol with compounds that inhibit metabolism or enhance intestinal permeability.

### Is bio-active resveratrol from Polygonum cuspidatum safe for individuals taking aspirin or NSAIDs?

While resveratrol from Polygonum cuspidatum is traditionally used for platelet support, combining it with aspirin or NSAIDs may have additive effects on platelet function and bleeding risk, particularly at high doses, though human clinical data is sparse. Individuals regularly taking these medications should consult a healthcare provider before adding resveratrol supplements, as the combination could theoretically increase bleeding risk. The safety of concurrent use has not been rigorously evaluated in controlled clinical trials. Current evidence does not support routine co-use without medical supervision.

### What evidence supports the antioxidant claims made about Polygonum cuspidatum resveratrol?

Antioxidant activity of resveratrol from Polygonum cuspidatum has been demonstrated in laboratory test-tube assays (DPPH, ABTS, and FRAP methods), which measure free-radical scavenging capacity in controlled conditions. However, in vitro antioxidant activity does not directly translate to biological benefits in the human body, as resveratrol's low bioavailability and rapid metabolism limit its systemic antioxidant impact. Human clinical trials investigating actual antioxidant effects and health outcomes from this ingredient remain limited and inconclusive. Marketing claims about antioxidant benefits should be viewed cautiously until more rigorous human evidence is published.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*